Natco Pharma Ltd.

Reserve Bank of India (RBI) has allowed Foreign Institutional Investors (FIIs)/Registered Foreign Portfolios Investors (RFPIs) to buy up to 31.50% of the paid up capital of Natco Pharma. Earlier, the FII limit in the company was 24%. The purchases could be made through primary market and stock exchanges.

The company has passed resolutions at its board of directors’ level and a special resolution by the shareholders, agreeing for enhancing the limit for the purchase of its equity shares and convertible debentures by FIIs/RFPIs.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.